CRF And VEITHsymposium Announce an Alliance Between Transcatheter Cardiovascular Therapeutics (TCT) and VEITHsymposium

New York, NY – June 19, 2019 – VEITHsymposium and the Cardiovascular Research Foundation (CRF) are pleased to announce an alliance between Transcatheter Cardiovascular Therapeutics (TCT) and the VEITHsymposium. TCT is the annual scientific symposium of CRF and the world’s premier educational meeting specializing in interventional cardiovascular medicine. VEITHsymposium is the leading global conference covering all aspects of vascular medicine, vascular surgery and endovascular intervention.

As part of this alliance, the two organizations will closely collaborate on creating educational content for physicians, surgeons and other healthcare professionals. The VEITHsymposium leadership will be actively involved in developing the endovascular program for TCT 2019, taking place September 25-29 in San Francisco, California. The VEITHsymposium group will also plan dedicated critical limb ischemia and aortic sessions at TCT 2019. Similarly, CRF will actively participate in the development of a two-day hands-on training pavilion and other interventional sessions at this year’s VEITHsymposium, which will take place November 19-23 in New York City.

“We are pleased to be partnering with such an esteemed educational conference as the VEITHsymposium,” said Juan F. Granada, MD, President and Chief Executive Officer of CRF. “Over the last 45 years, they have had a remarkable influence on medical education and innovation in the field which has had a tremendous impact on patient care.”

“This alliance between 2 leading continuing medical educational meetings has as its goal the provision of the best, most up-to-date information possible to all those specializing in the care of non-cardiac vascular disease patients,” said Frank J. Veith, Chairman of VEITHsymposium.  “This unique alliance will lead to better, more appropriate care for the increasing number of vascular disease patients around the world, while recognizing the reality that many specialties are involved in providing this care.”

“Vascular disease is a leading cause of death and disability,” said Sahil A. Parikh, MD, Director, Endovascular Services at the Center for Interventional Vascular Therapy at New York-Presbyterian/ Columbia University Irving Medical Center and Director of the Endovascular Program of TCT. “It’s critically important for physicians and other healthcare professionals to be educated and trained on the latest endovascular treatments. This alliance will help improve the survival and quality of life for patients with vascular disease by emphasizing multidisciplinary care of vascular patients.”

“Limitless opportunities for improved care of vascular patients is the primary goal of this new and exciting alliance between two well established giants in the area of education,” said Enrico Ascher, MD, Co-Chairman of VEITHsymposium. “Providing a balanced, progressive environment where all vascular care professionals can learn from each other is one other motivating factor that led to this arrangement. I’m certain that this new concept of working together for the benefit of our patients and for the advancement of science will succeed big time!”

About CRF, TCT, and TCTMD

The Cardiovascular Research Foundation (CRF) is a nonprofit research and educational organization dedicated to helping doctors improve survival and quality of life for people suffering from heart and vascular disease. For nearly 30 years, CRF has helped pioneer innovations in interventional cardiology and educated doctors on the latest treatments for heart disease.

Transcatheter Cardiovascular Therapeutics (TCT) is the annual scientific symposium of CRF and the world’s premier educational meeting specializing in interventional cardiovascular medicine. Now in its 31^st year, TCT features major medical research breakthroughs and gathers leading researchers and clinicians from around the world to present and discuss the latest evidence-based research in the field. TCT also includes interactive training where clinicians can gain vital skills to apply immediately to their practices.

TCTMD is the most comprehensive online resource in interventional cardiology and provides in-depth coverage of the percutaneous treatment of cardiovascular disease.

For more information about TCT/CRF, visit www.crf.org, www.tctconference.com, and www.tctmd.com.

For more information about VEITHsymposium, visit www.veithsymposium.org.

https://www.newswise.com/articles/crf-and-veithsymposium-announce-an-alliance-between-transcatheter-cardiovascular-therapeutics-tct-and-veithsymposium